Location History:
- Oxfordshire, GB (2018 - 2024)
- Abingdon, GB (2021 - 2024)
Company Filing History:
Years Active: 2018-2024
Title: The Innovative Contributions of Alice Claire Noel Brown
Introduction
Alice Claire Noel Brown is a distinguished inventor based in Oxfordshire, GB, renowned for her significant contributions to the field of oncolytic virotherapy. With a remarkable portfolio of 10 patents, her work is paving the way for innovative cancer treatments and therapeutic advancements.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Group B adenovirus encoding an anti-TCR-complex antibody or fragment." This patent discusses a replication-deficient oncolytic viral vector or capable group B oncolytic adenovirus selected from Ad11 and enadenotucirev. The invention encodes an antibody or a binding fragment for expression on the surface of a cancer cell, specifically targeting the CD3 protein of a T-cell receptor complex (TCR). Notably, the virus does not encode a B7 protein or any active fragment, highlighting its specificity and potential in pharmaceutical applications, particularly in cancer treatment. Another recent patent she developed involves oncolytic adenoviruses armed with heterologous genes, further showcasing her commitment to advancing cancer therapeutics.
Career Highlights
Alice has had an impactful career, with her expertise being harnessed by esteemed organizations such as Psioxus Therapeutics Limited and Akamis Bio Limited. Her innovative approaches and strategic insights have made significant contributions to the research and development of viral vectors in treating cancer.
Collaborations
Throughout her illustrious career, Alice has collaborated with prominent colleagues including Brian Robert Champion and Kerry David Fisher. These partnerships have enriched her research endeavors and propelled her innovations in the field of oncolytic virotherapy.
Conclusion
Alice Claire Noel Brown stands as a pioneering inventor in the realm of oncolytic therapies, driving forward the development of cutting-edge treatments for cancer. With her extensive patent portfolio and collaborative spirit, she continues to inspire new avenues of research and innovation in the medical field.